我要投票 三金SANJIN在口气清新剂行业中的票数:11
· 外 推 电 报 ·
2024-11-25 16:04:01 星期一

【三金SANJIN是哪个国家的品牌?】

三金SANJIN是什么牌子?「三金SANJIN」是 桂林三金药业股份有限公司 旗下著名品牌。该品牌发源于广西,由创始人邹节明在1994期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

桂林三金药业股份有限公司是三金集团的核心企业,主营中成药、天然药物的研发和生产,是国内较早生产现代中药制剂的厂家之一,也是广西医药龙头企业。1985年以来,桂林三金坚持改革创新,依靠科技进步和科学管理,从一个名不见经传的中药作坊小厂蜕变成为全国知名的现代中药企业。

三金作为区内外知名的高新技术企业,建有国家认定的企业技术中心、博士后科研工作站及广西中药产业化工程院等创新平台。多年来,一直致力推进和实施中药产业现代化规划,积极培养、提高企业的自主创新能力。目前公司的特色中药新药均由企业技术中心主导研制。目前,三金拥有200多个注册品种和13个药品剂型,拥有桂林西瓜霜、西瓜霜润喉片、三金片、脑脉泰胶囊等自主开发的特色品种42种。经过多年努力,三金在咽喉、口腔用药和泌尿系统用药方面已形成较强的专业和市场优势,代表产品三金西瓜霜系列、三金片。“三金”牌产品已行销海内外,并享有良好声誉。

2009年7月,桂林三金以高成长、高效益的崭新面貌,成功进入资本市场,迎来企业高速发展的新阶段。近年来,为积极响应桂林市委、市政府“向西发展,再造一个新桂林”的号召,也为解决企业生产基地及仓储设施分散与企业快速发展之间的矛盾,三金启动了“三金现代中药产业化技术改造工程”的建设。目前,该项目一期已经正式投产并实现了主要生产线的整体搬迁。

面对未来,三金将秉承“创新推动医药进步”的企业使命和“敢为先”企业精神,实施以中药制药为主体,致力发展生物制药和大健康产业的”一体两翼”发展战略,视质量、信誉为企业第一生命,突破创新,不断增强三金的竞争实力,锐意进取,以发展报国、回报投资者,以打造中国知名医药制造集团为目标,推动中药产业现代化、国际化!


英文翻译:Guilin Sanjin Pharmaceutical Co., Ltd. is the core enterprise of Sanjin group, which is mainly engaged in the research and development and production of Chinese patent medicine and natural medicine. It is one of the earliest manufacturers of modern Chinese medicine preparations in China, and also the leading enterprise of Guangxi medicine. Since 1985, Guilin Sanjin has persisted in reform and innovation, relying on scientific and technological progress and scientific management, and has transformed from an unknown small traditional Chinese medicine workshop into a well-known modern Chinese medicine enterprise in China. As a well-known high-tech enterprise inside and outside the zone, Sanjin has established a national recognized enterprise technology center, postdoctoral research workstation, Guangxi Institute of traditional Chinese medicine industrialization and other innovation platforms. Over the years, we have been committed to promoting and implementing the modernization plan of traditional Chinese medicine industry, and actively cultivating and improving the independent innovation ability of enterprises. At present, the company's characteristic new Chinese medicine is mainly developed by the enterprise technology center. At present, Sanjin has more than 200 registered varieties and 13 pharmaceutical dosage forms, and 42 self-developed characteristic varieties such as Guilin Watermelon cream, watermelon cream throat moistening tablet, Sanjin tablet, Naomaitai Capsule, etc. After years of efforts, Sanjin has formed strong professional and market advantages in throat, oral medicine and urinary system medicine, representing Sanjin watermelon cream series and Sanjin tablets. "Three gold" brand products have been sold at home and abroad, and enjoy a good reputation. In July 2009, Guilin Sanjin successfully entered the capital market and ushered in a new stage of rapid development of enterprises with a new look of high growth and high efficiency. In recent years, in order to actively respond to the call of Guilin municipal Party committee and municipal government to "develop to the West and rebuild a new Guilin", and to solve the contradiction between the scattered production base and storage facilities of enterprises and the rapid development of enterprises, Sanjin has launched the construction of "Sanjin modern Chinese medicine industrialization technology transformation project". At present, the first phase of the project has been officially put into operation and the overall relocation of the main production lines has been realized. In the future, Sanjin will adhere to the enterprise mission of "innovation promotes pharmaceutical progress" and the enterprise spirit of "dare to be the first", implement the development strategy of "one body and two wings" with traditional Chinese medicine as the main body, devote to the development of biopharmaceutical and big health industry, regard quality and reputation as the life of the enterprise, break through innovation, continuously enhance the competitiveness of Sanjin, forge ahead, serve the country and return with development Newspaper investors, with the goal of building a well-known Chinese pharmaceutical manufacturing group, to promote the modernization and internationalization of traditional Chinese medicine industry!

本文链接: https://www.waitui.com/brand/7e6028fbc.html 联系电话:0773-5843205

千城特选小程序码

7×24h 快讯

北京君正:未从英伟达购买IP,公司MPU芯片以CPU处理为主

36氪获悉,北京君正在互动平台表示,公司未从英伟达购买IP,公司MPU芯片以CPU处理为主。

4分钟前

美方将公布新的对华芯片出口限制?外交部:中方将坚定维护中企正当合法权益

在11月25日外交部例行记者会上,有记者提问称,美国商会称,拜登政府最早将于下周公布新的对华芯片出口限制措施。外交部对此有何评论?对此,发言人毛宁表示,中方一贯坚决反对美方泛化国家安全概念,滥用出口管制措施,对中国进行恶意的封锁和打压,这种行为严重违反市场经济规律和公平竞争原则,破坏国际经贸秩序,扰乱全球产供链的稳定,最终损害的是所有国家的利益。中方将采取坚决措施,坚定维护中国企业的正当合法权益。(环球时报)

4分钟前

欧洲央行Lane称不应该维持限制性利率太久,Kazaks认为下个月会降息

欧洲央行首席经济学家Philip Lane表示,欧洲央行应该能够在2025年把利率降至不再限制经济的水平。“我们不会提前承诺降息的确切速度,但我们将不得不逐步降低利率。”他在接受采访时说道,“货币政策不应该维持太长时间的限制性。否则经济将无法充分增长,我认为通胀将降至目标水平之下。”他强调指出,让通胀可持续地回到2%目标最后一步的大部分工作,将在明年完成。(新浪财经)

4分钟前

比亚迪2025年将推出新一代刀片电池

11月25日,比亚迪欧洲汽车销售事业部中亚地区总经理曹爽在第二十九届联合国气候变化大会(COP29)期间接受采访时表示,2025年比亚迪计划推出新一代刀片电池,将提高汽车的续航里程,并延长电池本身的使用寿命。(财联社)

4分钟前

德迈仕:公司1款激光雷达马达轴向大疆供货,应用于汽车自动驾驶系统

36氪获悉,德迈仕在互动平台表示,公司生产的1款激光雷达马达轴向大疆供货,应用于汽车自动驾驶系统,未用于大疆无人机中。

4分钟前

本页详细列出关于隆力奇Longrich的品牌信息,含品牌所属公司介绍,隆力奇Longrich所处行业的品牌地位及优势。
咨询